Healx
Work with us
Partnerships that power new rare disease treatments
True medical breakthroughs happen when industry, patient groups and academic institutions work together. Let’s collaborate to accelerate the development of novel treatments for rare diseases
Whilst cutting-edge AI technology is integral to our work, we couldn’t have achieved as much as we have done to date without the involvement of our partners. We welcome enquiries from groups interested in partnering with us to progress treatments for rare diseases.
Patient groups
Academic groups
Biotech and pharma
Partnerships
Ways of working together
The Rare Treatment Accelerator
Our Rare Treatment Accelerator (RTA) options or licenses academic, patient, and industry group drug redevelopment projects focused on rare diseases.
By combining our team, expertise and financial resources with your research and insights, we can get treatments to patients faster.
Healx pipeline
We work across a range of rare disease areas and have a number of treatments progressing towards the clinic. We welcome enquiries both from groups whose diseases of interest fit with our current portfolio, along with those from groups working on other rare conditions where relevant assets, resources and data are available.